MétaCan
Menu
Back to cohort
Record W4383215172 · doi:10.1093/ije/dyad098

Development of hybrid immunity during a period of high incidence of Omicron infections

2023· article· en· W4383215172 on OpenAlexfundno aff
Anja Frei, Marco Kaufmann, Rebecca Amati, Audrey Butty Dettwiler, Viktor von Wyl, Anna Maria Annoni, Julia Vincentini, Céline Pellaton, Giuseppe Pantaleo, Jan Fehr, Valérie D’Acremont, Murielle Bochud, Emiliano Albanese, Milo A. Puhan, Antonio Amendola, A Anagnostopoulos, Daniela Anker, Hélène E. Aschmann, Andrew S. Azman, Antoine Bal, Tala Ballouz, Hélène Baysson, Kleona Bezani, Annette Blattmann, Patrick Bleich, Patrick Bodenmann, Gaëlle Bryand Rumley, Peter Buttaroni, Anne-Linda Camerini, Arnaud Chioléro, Patricia Chocano-Bedoya, Prune Collombet, Laurie Corna, Luca Crivelli, Stéphane Cullati, Diana Sofia Da Costa Santos, Agathe Deschamps, Paola D’Ippolito, Anja Domenghino, Richard Dubos, Roxane Dumont, Olivier Duperrex, Julien Dupraz, Malik Egger, Emna El-May, Nacira El Merjani, Nathalie Engler, Adina Mihaela Epure, Lukas Erksam, Sandrine Estoppey, Marta Fadda, Vincent Faivre, Andrea Felappi, Maddalena Fiordelli, Antoine Flahault, Luc Fornerod, Cristina Fragoso Corti, Natalie Francioli, Marion Frangville, Irène Frank, Giovanni Franscella, Marco Geigges, Semira Gonseth, Clément Graindorge, Idris Guessous, E Harju, Séverine Harnal, Medea Imboden, Emilie Jendly, Ayoung Jeong, Christian R. Kahlert, Laurent Kaiser, Dirk Keidel, Simone Kessler, Philipp Köhler, Christine Krähenbühl, Susi Kriemler, Julien Lamour, Sara Levati, Pierre Lescuyer, Andrea Loizeau, Elsa Lorthe, Chantal Luedi, Jean‐Luc Magnin, Chantal Martinez, Éric Masserey, Dominik Menges, Gisela Michel, Rosalba Morese, Nicolai Mösli, Natacha Noël, Daniel H. Paris, Jérôme Pasquier, Francesco Pennacchio, Stefan M. Pfister, Giovanni Piumatti, Géraldine Poulain, Nicole Probst‐Hensch, Caroline Pugin, Nick Pullen, Thomas Radtke, Manuela Rasi, Aude Richard, Viviane Richard, Claude-François Robert, Pierre‐Yves Rodondi, Nicolas Rodondi, Serena Sabatini, Khadija Samir, Javier Sanchis Zozaya, Virginie Schlüter, Alexia Schmid, Valentine Schneider, Maria Schüpbach, Nathalie Schwab, Claire Semaani, Alexandre Speierer, Amélie Steiner-Dubuis, Silvia Stringhini, Stefano Tancredi, Stéphanie Testini, Julien Thabard, Mauro Tonolla, Nicolas Troillet, Agnė Ulytė, Sophie Vassaux, Thomas Vermes, Jennifer Villers, Cornelia Wagner, Rylana Wenger, Erin West, Ania Wisniak, Melissa Witzig, María-Eugenia Zaballa, Kyra D. Zens, Claire Zuppinger

Bibliographic record

VenueInternational Journal of Epidemiology · 2023
Typearticle
Languageen
FieldMedicine
TopicSARS-CoV-2 and COVID-19 Research
Canadian institutionsnot available
FundersDepartment of Epidemiology, Biostatistics and Occupational Health, McGill UniversityHôpitaux Universitaires de GenèveJohns Hopkins Bloomberg School of Public HealthUniversité de FribourgUniversity of BernSwiss School of Public HealthUniversität BaselMcGill UniversityUniversité de LausanneUniversité de GenèveInselspital, Universitätsspital BernUniversität ZürichBundesamt für GesundheitJohns Hopkins University
KeywordsSeroprevalenceImmunityVaccinationPopulationAntibodyIncidence (geometry)Neutralizing antibodyVirologyMedicineBiologyImmune systemImmunologySerology

Abstract

fetched live from OpenAlex

BACKGROUND: Seroprevalence and the proportion of people with neutralizing activity (functional immunity) against SARS-CoV-2 variants were high in early 2022. In this prospective, population- based, multi-region cohort study, we assessed the development of functional and hybrid immunity (induced by vaccination and infection) in the general population during this period of high incidence of infections with Omicron variants. METHODS: We randomly selected and assessed individuals aged ≥16 years from the general population in southern (n = 739) and north-eastern (n = 964) Switzerland in March 2022. We assessed them again in June/July 2022, supplemented with a random sample from western (n = 850) Switzerland. We measured SARS-CoV-2 specific IgG antibodies and SARS-CoV-2 neutralizing antibodies against three variants (ancestral strain, Delta, Omicron). RESULTS: Seroprevalence remained stable from March 2022 (97.6%, n = 1894) to June/July 2022 (98.4%, n = 2553). In June/July, the percentage of individuals with neutralizing capacity against ancestral strain was 94.2%, against Delta 90.8% and against Omicron 84.9%, and 50.6% developed hybrid immunity. Individuals with hybrid immunity had highest median levels of anti-spike IgG antibodies titres [4518 World Health Organization units per millilitre (WHO U/mL)] compared with those with only vaccine- (4304 WHO U/mL) or infection- (269 WHO U/mL) induced immunity, and highest neutralization capacity against ancestral strain (hybrid: 99.8%, vaccinated: 98%, infected: 47.5%), Delta (hybrid: 99%, vaccinated: 92.2%, infected: 38.7%) and Omicron (hybrid: 96.4%, vaccinated: 79.5%, infected: 47.5%). CONCLUSIONS: This first study on functional and hybrid immunity in the Swiss general population after Omicron waves showed that SARS-CoV-2 has become endemic. The high levels of antibodies and neutralization support the emerging recommendations of some countries where booster vaccinations are still strongly recommended for vulnerable persons but less so for the general population.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.004
Threshold uncertainty score0.009

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.078
GPT teacher head0.418
Teacher spread0.341 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations14
Published2023
Admission routes1
Has abstractyes

Explore more

Same venueInternational Journal of EpidemiologySame topicSARS-CoV-2 and COVID-19 ResearchFrench-language works237,207